Global Neuromodulation Competitive Landscape Professional Research Report 2025
Research Summary
Neuromodulation is a medical technique that involves the alteration of nerve activity through targeted delivery of electrical or pharmaceutical agents to specific neurological sites in the body. It is used to treat a variety of conditions, including chronic pain, movement disorders, and psychiatric conditions, by modulating the activity of neurons and neural circuits. Methods of neuromodulation include spinal cord stimulation, deep brain stimulation, and transcranial magnetic stimulation, among others. These interventions can help restore normal function, alleviate symptoms, and improve the quality of life for patients with otherwise difficult-to-treat neurological conditions.
According to DIResearch's in-depth investigation and research, the global Neuromodulation market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Neuromodulation include Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Synapse Biomedical, Inc., Nevro Corporation, NeuroSigma, NeuroPace, Neuronetics, BioControl Medical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neuromodulation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromodulation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neuromodulation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromodulation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neuromodulation Include:
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Synapse Biomedical, Inc.
Nevro Corporation
NeuroSigma
NeuroPace
Neuronetics
BioControl Medical
Neuromodulation Product Segment Include:
Internal Treatment
External Treatment
Neuromodulation Product Application Include:
Ischemia
Chronic Pain
Parkinson’s
Depression
Tremor
Epilepsy
Migraine
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Neuromodulation Industry PESTEL Analysis
Chapter 3: Global Neuromodulation Industry Porter’s Five Forces Analysis
Chapter 4: Global Neuromodulation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Neuromodulation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Neuromodulation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Neuromodulation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Neuromodulation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Neuromodulation Product by Type
- 1.2.1 Internal Treatment
- 1.2.2 External Treatment
- 1.3 Neuromodulation Product by Application
- 1.3.1 Ischemia
- 1.3.2 Chronic Pain
- 1.3.3 Parkinson’s
- 1.3.4 Depression
- 1.3.5 Tremor
- 1.3.6 Epilepsy
- 1.3.7 Migraine
- 1.4 Global Neuromodulation Market Size Analysis (2020-2032)
- 1.5 Neuromodulation Market Development Status and Trends
- 1.5.1 Neuromodulation Industry Development Status Analysis
- 1.5.2 Neuromodulation Industry Development Trends Analysis
- 2 Neuromodulation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Neuromodulation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Neuromodulation Market Analysis by Regions
- 4.1 Neuromodulation Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Neuromodulation Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Neuromodulation Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Neuromodulation Revenue Forecast by Region (2026-2032)
- 5 Global Neuromodulation Market Size by Type and Application
- 5.1 Global Neuromodulation Market Size by Type (2020-2032)
- 5.2 Global Neuromodulation Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Neuromodulation Market Size by Type
- 6.4 North America Neuromodulation Market Size by Application
- 6.5 North America Neuromodulation Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Neuromodulation Market Size by Type
- 7.4 Europe Neuromodulation Market Size by Application
- 7.5 Europe Neuromodulation Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Neuromodulation Market Size by Type
- 8.4 China Neuromodulation Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Neuromodulation Market Size by Type
- 9.4 APAC (excl. China) Neuromodulation Market Size by Application
- 9.5 APAC (excl. China) Neuromodulation Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Neuromodulation Market Size by Type
- 10.4 Latin America Neuromodulation Market Size by Application
- 10.5 Latin America Neuromodulation Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Neuromodulation Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Neuromodulation Market Size by Type
- 11.4 Middle East & Africa Neuromodulation Market Size by Application
- 11.5 Middle East & Africa Neuromodulation Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Neuromodulation Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Neuromodulation Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Neuromodulation Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Medtronic
- 13.1.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Medtronic Neuromodulation Product Portfolio
- 13.1.3 Medtronic Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Boston Scientific Corporation
- 13.2.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Boston Scientific Corporation Neuromodulation Product Portfolio
- 13.2.3 Boston Scientific Corporation Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Abbott
- 13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Abbott Neuromodulation Product Portfolio
- 13.3.3 Abbott Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 LivaNova
- 13.4.1 LivaNova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 LivaNova Neuromodulation Product Portfolio
- 13.4.3 LivaNova Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Synapse Biomedical, Inc.
- 13.5.1 Synapse Biomedical, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Synapse Biomedical, Inc. Neuromodulation Product Portfolio
- 13.5.3 Synapse Biomedical, Inc. Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Nevro Corporation
- 13.6.1 Nevro Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Nevro Corporation Neuromodulation Product Portfolio
- 13.6.3 Nevro Corporation Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 NeuroSigma
- 13.7.1 NeuroSigma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 NeuroSigma Neuromodulation Product Portfolio
- 13.7.3 NeuroSigma Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 NeuroPace
- 13.8.1 NeuroPace Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 NeuroPace Neuromodulation Product Portfolio
- 13.8.3 NeuroPace Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Neuronetics
- 13.9.1 Neuronetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Neuronetics Neuromodulation Product Portfolio
- 13.9.3 Neuronetics Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 BioControl Medical
- 13.10.1 BioControl Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 BioControl Medical Neuromodulation Product Portfolio
- 13.10.3 BioControl Medical Neuromodulation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Neuromodulation Industry Chain Analysis
- 14.2 Neuromodulation Industry Raw Material and Suppliers Analysis
- 14.2.1 Neuromodulation Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Neuromodulation Typical Downstream Customers
- 14.4 Neuromodulation Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook